Last reviewed · How we verify
control live attenuated mumps vaccine — Competitive Intelligence Brief
phase 3
Immunology
Biologic
Live · refreshed every 30 min
Target snapshot
control live attenuated mumps vaccine (control live attenuated mumps vaccine) — Sinovac Research and Development Co., Ltd.. The control live attenuated mumps vaccine works by introducing a weakened form of the mumps virus to stimulate an immune response.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| control live attenuated mumps vaccine TARGET | control live attenuated mumps vaccine | Sinovac Research and Development Co., Ltd. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- control live attenuated mumps vaccine CI watch — RSS
- control live attenuated mumps vaccine CI watch — Atom
- control live attenuated mumps vaccine CI watch — JSON
- control live attenuated mumps vaccine alone — RSS
Cite this brief
Drug Landscape (2026). control live attenuated mumps vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/control-live-attenuated-mumps-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab